SCHEMBL22926337

SCHEMBL22926337

CC(=O)c1ccc(-c2cc(Cl)ccc2F)cc1Cl

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.43
CASP1 P29466 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
SCN9A Q15858 1/20 0.42
MAOB P27338 2/20 0.42
MAOA P21397 1/20 0.42
ALDH1A1 P00352 3/20 0.40
MAPT P10636 2/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
MAPK1 P28482 1/20 0.40
HIF1A Q16665 1/20 0.40
FASN P49327 1/20 0.40
PSEN1 P49768 1/20 0.40
PSEN2 P49810 1/20 0.40
APH1B Q8WW43 1/20 0.40
NCSTN Q92542 1/20 0.40
APH1A Q96BI3 1/20 0.40
PSENEN Q9NZ42 1/20 0.40
AVPR2 P30518 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3097068 0.84 ACMSD (0.51) ALDH1A1MAPTPSEN1PSEN2APH1B
SCHEMBL29384783 0.79 TSHR (0.65) TSHRCASP1SMN1; SMN2ALDH1A1MAPT
SCHEMBL322161 0.79 TSHR (0.65) TSHRCASP1SMN1; SMN2ALDH1A1MAPT
SCHEMBL22926305 0.79 FASN (0.51) SMN1; SMN2MAOBMAOAALDH1A1MAPT
SCHEMBL3621421 0.77 MAOB (0.47) TSHRCASP1SMN1; SMN2MAOBMAOA
SCHEMBL8940388 0.76 P2RX1 (0.46) TSHRCASP1SMN1; SMN2MAOBMAOA
SCHEMBL14294262 0.76 ESR1 (0.50) KDM4E
SCHEMBL29392929 0.76 MAOB (0.58) TSHRCASP1SMN1; SMN2MAOBMAOA
SCHEMBL325429 0.76 MAOB (0.58) TSHRCASP1SMN1; SMN2MAOBMAOA
SCHEMBL14439661 0.75 ALDH1A1 (0.48) TSHRCASP1SMN1; SMN2MAOBMAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3587406-B1 2-HYDROXY-1-{4-[(4-PHENYLPHENYL)CARBONYL]PIPERAZIN-1-YL}ETHAN-1-ONE DERIVATIVES AND RELATED COMPOUNDS AS FATTY ACID SYNTHASE (FASN) INHIBITORS FOR THE TREATMENT OF CANCER FORMA THERAPEUTICS INC (US) 2021-01-27 EP disclosed